<DOC>
	<DOCNO>NCT01710462</DOCNO>
	<brief_summary>This superiority phase III study compare combination Pantoprazole Domperidone Pantoprazole isolate treatment gastroesophageal reflux disease . The hypothesis combination two medication unique capsule well patient decrease quantity time patient need take medicine day .</brief_summary>
	<brief_title>Clinical Study , Multicenter , Randomized With 2 Arms Pantoprazole + Domperidone Pantoprazole Isolated Gastroesophageal Reflux Disease</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<mesh_term>Domperidone</mesh_term>
	<criteria>1 . Subscription IC ; 2 . Age ≥ 18 year &lt; 70 year 3 . Diagnosis initial clinical previous symptomatic GERD ; 4 . Symptom score ≥ 4 ; 5 . Ability conduct examination endoscopy ; 6 . Ability perform washout drug class PPIs , H2 antagonists , prokinetics least 14 day . 1 . Presence esophagitis require intervention , esophageal varix , Barrett 's esophagus , scleroderma , ulcer ( gastric duodenal ) , atrophic gastritis , vagotomy pangastritis detect time study enrollment ; 2 . Eradication treatment H. pylorus complete less 15 day V0 ; 3 . Presence alarm symptom ( weight loss great 5 % last 60 day , evidence gastrointestinal bleeding ) ; 4 . Gastric esophageal surgery prior ( except simple ulcer closure ) ; 5 . Females pregnancy , lactation , wish become pregnant refuse use adequate contraception study period . 6 . Concomitant serious disease kidney failure , heart liver ; 7 . Suspected confirmed cancer except carcinoma situ nonmelanoma skin cancer diagnose last 5 year ; 8 . History gastric cancer relatives 1st degree ; 9 . Use illicit drug alcohol abuse accord investigator ; 10 . Values change ( outside normal range local laboratory ) leukocytes , platelet hemoglobin ; 11 . Significant change serum sodium , potassium , calcium creatinine ; 12 . Intolerance allergy component drug evaluate study ; 13 . Use antiinflammatory drug ( NSAIDs ) , antiemetic , macrolides systemic steroid period le 2 week prior study expect necessity prolong use study treatment ; 14 . Current use bisphosphonates , well need calcium channel blocker drug affect esophageal motility lower esophageal sphincter tone . 15 . Use schedule medication metabolize cytochrome CYP3A4 study ; 16 . Participation recent ( past 12 month ) participation clinical trial expect study clinical trial involve drug kind .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>